Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02895542 · ClinicalTrials.gov registry record
Preparatory Work to Assess Adherence to Oral Chemotherapy
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 86
- Enrollment target
NCT02895542: Completed study, sponsored by Wake Forest University Health Sciences.
NCT02895542 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 86 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02895542 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 86 participants
- Enrollment target
Study Summary
This study to find out more about how patients take their anticancer medications and challenges related to taking cancer medications.
Primary Outcome
Questions will be asked about the participants demographic background and health behaviors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2016-12-20 |
| Est. Completion | 2017-04-28 |
What the finished NCT02895542 record still lists
NCT02895542 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 86 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02895542 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02895542 about?
NCT02895542 is a clinical study titled "Preparatory Work to Assess Adherence to Oral Chemotherapy". This study to find out more about how patients take their anticancer medications and challenges related to taking cancer medications.
What is the current status of trial NCT02895542?
This trial is currently completed. The enrollment target is 86 participants. The study started on 2016-12-20. Estimated completion is 2017-04-28.
Who is sponsoring clinical trial NCT02895542?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI